Mpeg1 in Innate Immunity
先天免疫中的 Mpeg1
基本信息
- 批准号:8880309
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-15 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbscessAcid Fast Bacillae Staining MethodAnti-Bacterial AgentsAntibiotic ResistanceBacteremiaBacteriaBacterial InfectionsBone MarrowBreedingCell LineageCellsColitisColonCrohn&aposs diseaseCytolysisDataDiarrheaDisease modelEndosomesEpithelialGenerationsGenus MycobacteriumHealthImmune systemIn VitroInfectionInfectious Skin DiseasesInflammationInflammatory Bowel DiseasesInflammatory ResponseIntegral Membrane ProteinKnockout MiceLymphoid CellMeasuresMediatingMembraneMesenchymalModelingMolecularMucosal ImmunityMucous body substanceMuramidaseMusMyeloid CellsNatural ImmunityP-2Partner in relationshipPathogenesisPeritoneal MacrophagesPhagosomesPharmaceutical PreparationsPredispositionProteinsRoleSalmonellaSalmonella infectionsSalmonella typhimuriumSkinSodium Dextran SulfateTestingVacuoleVesicleWaterWeightWorkacid fast bacteriabactericidedrinkingdrug developmentinsightinterestkeratinocytekillingsmethicillin resistant Staphylococcus aureusmicrobiomenovelpathogenic bacteriaperforin 2polymerizationporin
项目摘要
DESCRIPTION (provided by applicant): In this revised application we show that Perforin-2 (Mpeg1) deficient mice are unable to clear orogastric infection with Salmonella typhimurium and epicutaneous infection with methicillin resistant Staphylococcus aureus (MRSA). Wild type, Perforin-2 sufficient littermates clear both types of bacteria. These findings support our previous in vitro data that showed that Perforin-2 is essential for clearing intracellular bacterial infections. Perforin-2 is expressed ubiquitously: constitutive or inducible by IFNs in all cells derived from endodermal, ectodermal, neuroectodermal and mesenchymal cells. Our data also suggest that killing of bacteria inside cells is responsible fo the inflammatory response observed in bacterial infections and required for bacterial clearance. Our new data in the dextran sodium sulfate model of inflammatory bowel disease suggest that P-2 is responsible for causing the inflammatory response providing novel insights into the pathogenesis of IBD which may be important for developing treatment options for Crohn's disease. In addition, the role of P-2 for anti-bacterial defense provides opportunities for drug development against antibiotic resistant bacterial infections. In ths application we will pursue work in three specific aims. In the first aim we will study mucosal immunity in P-2 sufficient and P-2 deficient mice to orogastric infection with Salmonela typhimurium and determine the role and molecular mechanisms of the inflammatory response in relation to P-2. In the second specific aim we will study the role of P-2 in the induction of diarrhea in the disease model of dextran sodium sulfate (DSS) and the role of P-2 in the composition of the microbiome. In the third specific aim, the susceptibility of P-2 deficint mice to methicillin resistant Staphylococcus aureus (MRSA) will be investigated and the molecular mechanism of P-2 mediated killing of MRSA in keratinocytes studied.
描述(由申请人提供):在此修订后的应用中,我们表明,缺陷的小鼠无法用鼠伤寒沙门氏菌和耐甲氧西林抗甲氧西林的金黄色葡萄球菌(MRSA)清除胃胃感染。野生型,穿孔2足够的同窝仔清除两种类型的细菌。这些发现支持了我们以前的体外数据,这些数据表明,穿孔蛋白-2对于清除细胞内细菌感染至关重要。 Perforin-2普遍表达:在所有源自内胚层,外胚层,神经皮质和间质细胞的细胞中,由IFN诱导或诱导。我们的数据还表明,细胞内细菌的杀死是导致细菌感染中观察到的炎症反应的原因,细菌清除所需的炎症。我们在炎症性肠病硫酸钠模型中的新数据表明,P-2负责引起炎症反应,从而提供了对IBD发病机理的新见解,这对于为克罗恩病开发治疗方案可能很重要。此外,P-2在抗菌防御中的作用为抗抗生素耐药细菌感染提供了机会。在应用程序中,我们将以三个特定目标进行工作。在第一个目的中,我们将研究P-2的粘膜免疫力足够和P-2缺乏小鼠对胃鼠伤寒的胃感染,并确定炎症反应与P-2有关的作用和分子机制。在第二个特定目的中,我们将研究P-2在腹泻诱导中的作用在硫酸钠疾病模型中(DSS)和P-2在微生物组组成中的作用。 在第三个特定目的中,将研究P-2缺陷小鼠对甲氧西林抗甲氧西林金黄色葡萄球菌(MRSA)的敏感性,并研究了正在研究的角质形成细胞中P-2介导的MRSA杀死的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ECKHARD R PODACK其他文献
ECKHARD R PODACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ECKHARD R PODACK', 18)}}的其他基金
Response to and protection by gp96SIVIg/TNFSF13 and gp96SIVIg/TNFSF15 vaccines
gp96SIVIg/TNFSF13 和 gp96SIVIg/TNFSF15 疫苗的反应和保护
- 批准号:
8198211 - 财政年份:2011
- 资助金额:
$ 38.38万 - 项目类别:
Generation of gp96SIVIg/TNFSF13 and gp96SIVIg/TNFSF15 vaccinesVaccines
gp96SIVIg/TNFSF13 和 gp96SIVIg/TNFSF15 疫苗的生成疫苗
- 批准号:
8198209 - 财政年份:2011
- 资助金额:
$ 38.38万 - 项目类别:
Mechanisms of mucosal protection by HPV-SIV and gp96-lg-SIV vaccines
HPV-SIV 和 gp96-lg-SIV 疫苗的粘膜保护机制
- 批准号:
8193660 - 财政年份:2011
- 资助金额:
$ 38.38万 - 项目类别:
Induction of mucosal SIV immunity in non human primates by secreted Hsp-Gp96
通过分泌的 Hsp-Gp96 诱导非人灵长类动物粘膜 SIV 免疫
- 批准号:
7911001 - 财政年份:2009
- 资助金额:
$ 38.38万 - 项目类别:
Induction of mucosal SIV immunity in non human primates by secreted Hsp-Gp96
通过分泌的 Hsp-Gp96 诱导非人灵长类动物粘膜 SIV 免疫
- 批准号:
7786796 - 财政年份:2007
- 资助金额:
$ 38.38万 - 项目类别:
相似海外基金
Computational Assembly of Beta Barrel Membrane Protein
β 桶膜蛋白的计算组装
- 批准号:
8546506 - 财政年份:2007
- 资助金额:
$ 38.38万 - 项目类别:
Computational Assembly of Beta Barrel Membrane Protein
β 桶膜蛋白的计算组装
- 批准号:
7586266 - 财政年份:2007
- 资助金额:
$ 38.38万 - 项目类别:
Computational Assembly of Beta Barrel Membrane Protein
β 桶膜蛋白的计算组装
- 批准号:
7213136 - 财政年份:2007
- 资助金额:
$ 38.38万 - 项目类别:
Computational Assembly of Beta Barrel Membrane Protein
β 桶膜蛋白的计算组装
- 批准号:
7356031 - 财政年份:2007
- 资助金额:
$ 38.38万 - 项目类别:
Computational Assembly of Beta Barrel Membrane Protein
β 桶膜蛋白的计算组装
- 批准号:
8034791 - 财政年份:2007
- 资助金额:
$ 38.38万 - 项目类别: